Repeat administration of drugs as a means to assess the genetic component in pharmacological variability

被引：32

作者：

Kalow, W ^{[1
]}

Endrenyi, L ^{[1
]}

Tang, BK ^{[1
]}

机构：

[1] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada

来源：

PHARMACOLOGY | 1999年 / 58卷 / 06期

关键词：

D O I：

10.1159/000028292

中图分类号：

R9 [药学];

学科分类号：

1007 [药学];

摘要：

引用

页码：281 / 284

页数：4

共 13 条

[1]

INTRAINDIVIDUAL VARIATION IN DRUG DISPOSITION [J].

ALVARES, AP ;

KAPPAS, A ;

EISEMAN, JL ;

ANDERSON, KE ;

PANTUCK, CB ;

PANTUCK, EJ ;

HSIAO, KC ;

GARLAND, WA ;

CONNEY, AH .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :407-419

[2]

Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydromethylantipyrine, and norantipyrine formation [J].

Engel, G ;

Hofmann, U ;

Heidemann, H ;

Cosme, J ;

Eichelbaum, M .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 59 (06) :613-623

[3]

Kalow W, 1998, PHARMACOGENETICS, V8, P283

[4]

Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam [J].

Kashuba, ADM ;

Bertino, JS ;

Rocci, ML ;

Kulawy, RW ;

Beck, DJ ;

Nafziger, AN .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (03) :269-277

[5]

GENETIC-VARIATION IN RATES OF ANTIPYRINE METABOLITE FORMATION - A STUDY IN UNINDUCED TWINS [J].

PENNO, MB ;

DVORCHIK, BH ;

VESELL, ES .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (08) :5193-5196

[6]

Genetic anticipation: fact or artifact, genetics or epigenetics? [J].

Petronis, A ;

Kennedy, JL ;

Paterson, AD .

LANCET, 1997, 350 (9088) :1403-1404

[7]

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 [J].

Rebbeck, TR ;

Jaffe, JM ;

Walker, AH ;

Wein, AJ ;

Malkowicz, SB .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (16) :1225-1229

[8]

Assays for CYP1A2 by testing in vivo metabolism of caffeine in humans [J].

Tang, BK ;

Kalow, W .

CYTOCHROME P450, PT B, 1996, 272 :124-131

[9]

GENETIC CONTROL OF DRUG LEVELS IN MAN - PHENYLBUTAZONE [J].

VESELL, ES ;

PAGE, JG .

SCIENCE, 1968, 159 (3822) :1479-&

[10]

GENETIC CONTROL OF DICUMAROL LEVELS IN MAN [J].

VESELL, ES ;

PAGE, JG .

JOURNAL OF CLINICAL INVESTIGATION, 1968, 47 (12) :2657-&

← 1 2 →